An Experimental Weight-Loss Drug Cut Osteoarthritis Pain in Half for Nearly 7 in 10 Patients. The Biggest Question Remains Unanswered
· inc.com · popularity 21/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at inc.com →
Summary
Two critical phase 3 trials conducted by researchers at Northwestern University found that high doses of a new drug had an unexpected benefit.
Found in: Inc.. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 1.